AngioDynamics, Inc. Stock price
Equities
ANGO
US03475V1017
Medical Equipment, Supplies & Distribution
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.7 USD | +5.56% | +1.97% | -27.30% |
Financials (USD)
Sales 2024 * | 312M | Sales 2025 * | 316M | Capitalization | 227M |
---|---|---|---|---|---|
Net income 2024 * | -6M | Net income 2025 * | -40M | EV / Sales 2024 * | 0.73 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 0.72 x |
P/E ratio 2024 * |
-38
x | P/E ratio 2025 * |
-5.64
x | Employees | 815 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 94.13% |
Latest transcript on AngioDynamics, Inc.
1 day | +5.56% | ||
1 week | +1.97% | ||
Current month | +3.83% | ||
1 month | -4.84% | ||
3 months | -29.10% | ||
6 months | -21.27% | ||
Current year | -27.30% |
Managers | Title | Age | Since |
---|---|---|---|
James Clemmer
CEO | Chief Executive Officer | 60 | 16-03-31 |
Director of Finance/CFO | 49 | 08-05-31 | |
Juan Serna
CTO | Chief Tech/Sci/R&D Officer | - | 16-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jan Reed
BRD | Director/Board Member | 63 | 16-11-08 |
Howard Donnelly
CHM | Chairman | 63 | 04-02-29 |
Wesley Johnson
BRD | Director/Board Member | 65 | 07-01-28 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.17% | 26 M€ | -0.05% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-03-27 | 5.7 | +5.56% | 505,397 |
24-03-26 | 5.4 | +2.47% | 381,691 |
24-03-25 | 5.27 | -1.68% | 334,226 |
24-03-22 | 5.36 | -2.90% | 269,057 |
24-03-21 | 5.52 | -1.25% | 337,245 |
Delayed Quote Nasdaq, March 27, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-27.30% | 227M | |
+3.10% | 197B | |
+1.11% | 71.22B | |
+12.40% | 53.77B | |
+19.12% | 48.75B | |
+6.87% | 44.22B | |
+11.92% | 28.85B | |
+11.57% | 27.62B | |
+10.13% | 28.57B | |
+19.96% | 26.73B |